|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM199908702 |
003 |
DE-627 |
005 |
20231223215534.0 |
007 |
cr uuu---uuuuu |
008 |
231223s2010 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/la102272d
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0666.xml
|
035 |
|
|
|a (DE-627)NLM199908702
|
035 |
|
|
|a (NLM)20666507
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Seo, Minseok
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Microfluidic assembly of monodisperse, nanoparticle-incorporated perfluorocarbon microbubbles for medical imaging and therapy
|
264 |
|
1 |
|c 2010
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 27.12.2010
|
500 |
|
|
|a Date Revised 02.09.2010
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a New medical imaging contrast agents that permit multiple imaging and therapy applications using a single agent can result in more accurate diagnosis and local treatment of diseased tissue. Solid nanoparticles (NPs) (5-150 nm in size) have emerged as promising imaging and therapy agents, as have micrometer-scale, perfluorocarbon gas-filled microbubbles (MBs) used in patients as intravascular ultrasound contrast agents. We propose that the modular combination of small, solid NPs and larger, highly compressible MBs into a single agent is an effective way to attain the desired complementary and hybrid properties of two very different agents. Presented here is a new strategy for the simple and robust incorporation of various medical NPs with monodisperse MBs based upon the controlled pH-based regulation of the electrostatic attraction between NPs and the MB shell. Using this simple approach, microfluidic-generated, protein-lipid-coated, perfluorobutane MBs (with size control down to 3 microm) were incorporated with silica-coated NPs, including CdSe/ZnS quantum dots, gold nanorods, iron oxide NPs, and Gd-loaded mesoporous silica NPs. The silica interface permits NP inclusion within MBs to be independent of NP composition, morphology, and size. Significantly, the NP-incorporated MBs (NP-MBs) diluted in saline were detectable using low-pressure ultrasound, and the monodisperse MB platform can be produced at high-throughput, sufficient for in vivo usage (10(6) MB/sec). The modular synthesis of a variety of NP-MBs can facilitate flexible, user-defined, multifunctional imaging and therapy agents tailored for specific applications and disease types
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Research Support, U.S. Gov't, Non-P.H.S.
|
650 |
|
7 |
|a Fluorocarbons
|2 NLM
|
700 |
1 |
|
|a Gorelikov, Ivan
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Williams, Ross
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Matsuura, Naomi
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1992
|g 26(2010), 17 vom: 07. Sept., Seite 13855-60
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
773 |
1 |
8 |
|g volume:26
|g year:2010
|g number:17
|g day:07
|g month:09
|g pages:13855-60
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/la102272d
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 26
|j 2010
|e 17
|b 07
|c 09
|h 13855-60
|